Trial Profile
Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia During the Influenza Season (U18).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2018
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Antibacterials; Antivirals; Zanamivir
- Indications Bacterial infections; Community-acquired pneumonia; Influenza virus infections; Respiratory tract infections
- Focus Therapeutic Use
- Acronyms RETOS
- 11 Apr 2018 Primary endpoint (Short-term Mortality) has not been met, according to results published in the Clinical Infectious Diseases.
- 11 Apr 2018 Primary endpoint (Re-hospitalization) has not been met, according to results published in the Clinical Infectious Diseases.
- 11 Apr 2018 Primary endpoint (Transfer to ICU After 24 h) has not been met, according to results published in the Clinical Infectious Diseases.